About Aetion
Aetion is a company based in New York (United States) founded in 2012 was acquired by Datavant in May 2025. Aetion has raised $203.6 million across 5 funding rounds from investors including Amgen, UCB and Datavant. Aetion has completed 1 acquisition, including Replica Analytics. Aetion offers products and services including Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services. Aetion operates in a competitive market with competitors including Aledade, Lumeris, Arcadia, Evolent and Advantum Health, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aetion, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aetion
Aetion offers a comprehensive portfolio of products and services, including Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services.
Platform for managing and analyzing longitudinal health data
App for generating quick insights from real-world data
App for examining data to support critical healthcare decisions
App using AI for synthetic health data generation
Services to accelerate real-world evidence strategies
People of Aetion
Unlock access to complete
Unlock access to complete
Funding Insights of Aetion
Aetion has successfully raised a total of $203.6M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $110 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aetion
Aetion has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, UCB and Datavant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked |
Investor details for Aetion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aetion
Aetion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Replica Analytics.
Investment portfolio details for Aetion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Synthetic data is generated from real datasets with privacy assurance.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Aetion
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aetion
Detailed financials for Aetion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aetion Comparisons
Peer comparison for Aetion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aetion
Aetion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aledade, Lumeris, Arcadia, Evolent and Advantum Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Primary care physician platform for patient care delivery is provided.
|
|
| Locked | Locked | Locked |
Lumeris offers population management and accountable care solutions
|
|
| Locked | Locked | Locked |
AI-based healthcare data analytics platform is provided for organizations.
|
|
| Locked | Locked | Locked |
Intelligent solutions for complex health conditions are delivered through partnerships.
|
|
| Locked | Locked | Locked |
Healthcare providers are supported in shifting to value-based care models.
|
Detailed competitors of Aetion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aetion
Complete news archive for Aetion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aetion
Aetion was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Aetion is headquartered in New York, United States. It is registered at New York, New York, United States.
Aetion is a funded company, having raised a total of $203.6M across 5 funding rounds to date.
Aetion provides payerprovider, biopharma and medical device customers with a platform which combines science with computing technology to allow them to gain insights into the clinical and financial status of a population, measure and compare the effectiveness and value of treatments and provider practices and realize value-based contracting. The Aetion Evidence Platform works with all healthcare data including claims, electronic health records, registries, and clinical trials. Aetions Evidence Generation application helps payers rapidly determine what treatments and medical interventions work in the real world. The Aetion Evidence Platform provides analytic methods and real-time evidence that allow payers to generate risk-adjusted insights and to fully quantify and communicate the value in their populations. The platform also enables payers and providers to collaborate in real-time with biopharmaceutical and medical device companies to develop therapeutic insights and make smart choices in patient care.
Aetion offers Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services.
Aetion has made 1 acquisition, including Replica Analytics.
Aetion has 18 investors. Key investors include Amgen, UCB, Datavant, Warburg Pincus, and Lakestar.